Results 231 to 240 of about 7,838,390 (295)

The impact of acting training on emotion recognition and expression: a systematic review. [PDF]

Front Psychol
Chu VC, Chin YW, Chou MM, Lavi I, Seaton M, Labidi E, Ong JY, Feaver I, Wu AF.   +8 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Psychometric evaluation of the ethical caring competency scale among Iranian Nurses: A methodological study. [PDF]

PLoS One
Jafari Rahim Abad Y, Saadati K, Ghaffari F.   +2 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Current practices and challenges in the management of acute bacterial skin and skin structure infections (ABSSSI): results from an Italian multicentre survey with expert discussion. [PDF]

JAC Antimicrob Resist
Gazzola L, Augello M, Cavinato S, Briozzo A, D'Amico F, Schiano Moriello N, Segala FV, Frallonardo L, Di Gennaro F, Saracino A, Tacconi D, Gilio M, Frontuto M, Parruti G, Cattelan A, Marchetti G.   +15 more
europepmc   +1 more source

Out in Front Board of Directors Meeting Agenda

, 2016
Out in Front
core  

Attribute development for a discrete choice experiment to examine preferences for long-acting HIV prevention products among pregnant and breastfeeding women. [PDF]

Sci Rep
Ngugi SM, Echoka E, Were V, Thuo N, Ogello V, Gikwa M, Muteti N, Mwangi P, Kazungu J, Ngure K.   +9 more
europepmc   +1 more source

Out in Front Graduation Ceremony Event Outline 2016

, 2016
Out in Front
core  

Safety analysis of long-acting dual bronchodilator after market approval: a real-world study from FDA Adverse Event Reporting System (FAERS) database. [PDF]

J Thorac Dis
Gao S, Zhuang W, Song Q, Yan D, Chen L, Lai Z, Cheng Y, Yang X, Hu S.   +8 more
europepmc   +1 more source